Collegium Pharmaceutical (COLL)
(Delayed Data from NSDQ)
$39.07 USD
+0.14 (0.36%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $39.10 +0.03 (0.08%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth F Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
COLL 39.07 +0.14(0.36%)
Will COLL be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for COLL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for COLL
Are Medical Stocks Lagging Context Therapeutics Inc. (CNTX) This Year?
Collegium Pharmaceutical (COLL) Upgraded to Buy: Here's Why
COLL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock?
Collegium Pharmaceutical (COLL) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Collegium Pharmaceutical (COLL) Beats Q2 Earnings and Revenue Estimates
Other News for COLL
Insider Sale: EVP and Chief Medical Officer Thomas Smith Sells 9,593 Shares of Collegium ...
IHF: Healthcare Dashboard For September
Insider Sale: EVP and General Counsel Shirley Kuhlmann Sells 20,225 Shares of Collegium ...
S&P Global To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Thursday
The Analyst Landscape: 4 Takes On Collegium Pharmaceutical